Cargando…
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
INTRODUCTION: Drug repositioning is a strategy to identify a new therapeutic indication for molecules that have been approved for other conditions, aiming to speed up the traditional drug development process and reduce its costs. The high prevalence and incidence of coronavirus disease 2019 (COVID-1...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118228/ https://www.ncbi.nlm.nih.gov/pubmed/37081137 http://dx.doi.org/10.1007/s00228-023-03486-4 |